Hutchens & Kramer Investment Management Group, LLC Dexcom Inc Transaction History

Hutchens & Kramer Investment Management Group, LLC

  • $162 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
SELL
$84.98 - $122.67 $91,013 - $131,379
-1,071 Reduced 37.53%
1,783 $201,000
Q3 2022

Nov 14, 2022
BUY
$76.35 - $94.18 $6,337 - $7,816
83 Added 3.0%
2,854 $243,000
Q2 2022

Aug 15, 2022
BUY
$67.99 - $132.89 $138,767 - $271,228
2,041 Added 279.59%
2,771 $215,000
Q4 2021

May 16, 2022
BUY
$129.87 - $162.82 $94,805 - $118,858
730 New
730 $339,000

Others Institutions Holding DXCM

# of Institutions
1,013
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Hutchens & Kramer Investment Management Group, LLC Portfolio

Follow Hutchens & Kramer Investment Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutchens & Kramer Investment Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hutchens & Kramer Investment Management Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email